Combined sub-optimal doses of rosuvastatin and bexarotene impair angiotensin II-induced arterial mononuclear cell adhesion through inhibition of Nox5 signaling pathways and increased RXR/PPARα and RXR/PPARγ interactions.
about
Combined sub-optimal doses of rosuvastatin and bexarotene impair angiotensin II-induced arterial mononuclear cell adhesion through inhibition of Nox5 signaling pathways and increased RXR/PPARα and RXR/PPARγ interactions.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Combined sub-optimal doses of ...... Rα and RXR/PPARγ interactions.
@ast
Combined sub-optimal doses of ...... Rα and RXR/PPARγ interactions.
@en
type
label
Combined sub-optimal doses of ...... Rα and RXR/PPARγ interactions.
@ast
Combined sub-optimal doses of ...... Rα and RXR/PPARγ interactions.
@en
prefLabel
Combined sub-optimal doses of ...... Rα and RXR/PPARγ interactions.
@ast
Combined sub-optimal doses of ...... Rα and RXR/PPARγ interactions.
@en
P2093
P2860
P50
P356
P1476
Combined sub-optimal doses of ...... ARα and RXR/PPARγ interactions
@en
P2093
Aida Collado
Aranzazu Martinez de Marañón
Herminia Gonzalez-Navarro
Laura Piqueras
Paula Escudero
P2860
P304
P356
10.1089/ARS.2014.5969
P577
2015-03-09T00:00:00Z